A rapid direct radioimmunoassay for type C virus group-specific antigen and antibody.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 4343114)

Published in Virology on October 01, 1972

Authors

S Oroszlan, M M White, R V Gilden, H P Charman

Articles citing this

Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells. Proc Natl Acad Sci U S A (1973) 4.39

Homology between type-C viruses of various species as determined by molecular hybridization. Proc Natl Acad Sci U S A (1973) 2.90

Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues. J Exp Med (1973) 2.13

Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus. J Exp Med (1974) 2.12

Expression of endogenous RNA C-type virus group-specific antigens in mammalian cells. J Virol (1973) 1.45

Radioimmunoassay for avian C-type virus group-specific antigen: detection in normal and virus-transformed cells. J Virol (1973) 1.34

Major structural proteins of type B, type C, and type D oncoviruses share interspecies antigenic determinants. Proc Natl Acad Sci U S A (1980) 1.18

Oncogenicity of an endogenous C-type virus chemically activated from mouse cells in culture. J Virol (1974) 1.10

Immunological properties of two polypeptides of Mason-Pfizer monkey virus. J Virol (1974) 1.10

Radioimmunoassay for the major structural protein of hamster type C viruses. J Virol (1974) 0.96

Detection and quantification of type C viral proteins in tissues and sera with an enzyme immunoassay. Infect Immun (1980) 0.85

Immunopathogenicity and oncogenicity of murine leukemia viruses. II. Infection of mice and rats with Scripps leukemia virus. Am J Pathol (1976) 0.82

Radioimmunoassay for intact Gross mouse leukemia virus. Proc Natl Acad Sci U S A (1976) 0.81

Modified radioimmunoassay for murine sarcoma-leukemia virus group-specific antigen. Appl Microbiol (1974) 0.81

Increased survival times of New Zealand hybrid mice immunosuppressed by graft-versus-host reactions. Clin Exp Immunol (1976) 0.79

Expression of the major internal viral polypeptide in cells transformed by wild-type and temperature-sensitive murine sarcoma virus. J Virol (1974) 0.75

Articles by these authors

Has the California tobacco control program reduced smoking? JAMA (1998) 7.38

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science (1986) 6.53

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science (1985) 6.48

Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A (1986) 5.55

Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science (1984) 5.43

Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science (1985) 5.42

Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. Proc Natl Acad Sci U S A (1985) 5.36

Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification. Proc Natl Acad Sci U S A (1983) 5.12

A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology (1974) 5.01

Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology (1985) 4.65

Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst (1994) 4.59

Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J Immunol (1983) 4.51

Human immunodeficiency viruses. Science (1986) 4.34

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science (1985) 4.31

In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid. J Virol (1983) 4.09

Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J Virol (1988) 4.06

Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein. Science (1985) 3.97

Home smoking restrictions: which smokers have them and how they are associated with smoking behavior. Nicotine Tob Res (1999) 3.93

C-type virus associated with gibbon lymphosarcoma. Nat New Biol (1972) 3.77

Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis. Proc Natl Acad Sci U S A (1970) 3.71

Thin-layer chromatography of sub-nanomole amounts of phenylthiohydantoin (PTH) amino acids on polyamide sheets. Anal Biochem (1973) 3.66

Interactions of retroviral structural proteins with single-stranded nucleic acids. J Biol Chem (1987) 3.62

Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus. Science (1982) 3.55

Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science (1985) 3.27

Dimeric structure of single chloride channels from Torpedo electroplax. Proc Natl Acad Sci U S A (1984) 3.22

Association between household and workplace smoking restrictions and adolescent smoking. JAMA (2000) 3.22

Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J Biol Chem (1981) 3.21

Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol (1983) 3.10

Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. AIDS Res Hum Retroviruses (1987) 3.03

Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins. J Virol (1987) 3.02

Fatty acylation of proteins. Annu Rev Cell Biol (1988) 2.92

Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J Virol (1984) 2.91

Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus. J Virol (1982) 2.89

Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus. Proc Natl Acad Sci U S A (1978) 2.87

Contamination of skin and clothing of accident and emergency personnel. BMJ (1992) 2.84

Proteins of the murine C-type RNA tumour viruses: isolation of a group-specific antigen by isoelectric focusing. J Gen Virol (1970) 2.80

C-type virus released from cultured human rhabdomyosarcoma cells. Nat New Biol (1972) 2.78

Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus. J Virol (1998) 2.77

Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. J Virol (1986) 2.77

Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J Virol (1988) 2.76

Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science (1988) 2.76

Coexistence of intraspecies and interspecies specific antigenic determinants on the major structural polypeptide of mammalian C-type viruses. Nat New Biol (1971) 2.70

Was there significant tax evasion after the 1999 50 cent per pack cigarette tax increase in California? Tob Control (2002) 2.67

Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol (1986) 2.65

A voltage-gated anion channel from the electric organ of Torpedo californica. J Biol Chem (1979) 2.65

Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses. J Biol Chem (1982) 2.59

A micromethod for complete removal of dodecyl sulfate from proteins by ion-pair extraction. Anal Biochem (1979) 2.57

Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus. Proc Natl Acad Sci U S A (1982) 2.57

Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease. J Virol (1985) 2.53

The gag and pol genes of bovine leukemia virus: nucleotide sequence and analysis. Virology (1985) 2.53

The group-specific antigen and other structural proteins of hamster and mouse C-type viruses. Virology (1971) 2.46

The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating. Mol Pharmacol (1995) 2.45

Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus. J Virol (1985) 2.43

Sarcoma-virus-related RNA sequences in normal rat cells. Proc Natl Acad Sci U S A (1974) 2.38

5-Bromo-2'-deoxyuridine potentiation of transformation of rat-embryo cells induced in vitro by 3-methylcholanthrene: induction of rat leukemia virus gs antigen in transformed cells. Proc Natl Acad Sci U S A (1973) 2.32

Separation of amino acid phenylthiohydantoins by high-performance liquid chromatography on phenylalkyl support. Anal Biochem (1980) 2.30

Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins. J Virol (1986) 2.28

A voltage-dependent chloride conductance channel from Torpedo electroplax membrane. Ann N Y Acad Sci (1980) 2.26

Myristylation of gag-onc fusion proteins in mammalian transforming retroviruses. Virology (1984) 2.22

Species-specific and interspecific antigenic determinants associated with the structural protein of feline C-type virus. Proc Natl Acad Sci U S A (1971) 2.20

Structural characterization of the avian retrovirus reverse transcriptase and endonuclease domains. J Biol Chem (1985) 2.18

Post-translational modification of Rauscher leukemia virus precursor polyproteins encoded by the gag gene. J Virol (1979) 2.16

A comparison of the replication cycles of simian virus 40 in human diploid and African green monkey kidney cells. Virology (1966) 2.13

Capsid protein VP4 of poliovirus is N-myristoylated. Proc Natl Acad Sci U S A (1987) 2.12

Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells. Proc Natl Acad Sci U S A (1984) 2.12

Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus. Proc Natl Acad Sci U S A (1983) 2.11

Simian AIDS: isolation of a type D retrovirus and transmission of the disease. Science (1984) 2.10

Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK. Curr Top Microbiol Immunol (1985) 2.09

Amino acid sequence analysis of reverse transcriptase subunits from avian myeloblastosis virus. J Virol (1980) 2.09

Alterations in the characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses. J Natl Cancer Inst (1969) 2.08

Protein kinase associated with RNA tumor viruses and other budding RNA viruses. Virology (1972) 2.01

DNA polymerase activity associated with RNA tumor viruses. Proc Natl Acad Sci U S A (1970) 2.00

Evidence for a functional change in the plasma membrane of murine sarcoma virus-infected mouse embryo cells. Transport and transport-associated phosphorylation of 14C-2-deoxy-D-glucose. J Biol Chem (1970) 1.99

The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology (1984) 1.98

Translational suppression in retroviral gene expression. Adv Virus Res (1992) 1.93

The inactivation of simian virus 40 infectivity and antigen-inducing capacity by ultraviolet light. Virology (1965) 1.93

Activation of squid axon K+ channels. Ionic and gating current studies. J Gen Physiol (1985) 1.92

The where, what and how of ribosomal frameshifting in retroviral protein synthesis. Trends Biochem Sci (1990) 1.92

Purification and immunological characterization of the major internal protein of the RD-114 virus. Proc Natl Acad Sci U S A (1972) 1.92

Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins. FEBS Lett (1991) 1.90

Complete amino acid sequence of the basic nucleic acid binding protein of feline leukemia virus. Virology (1984) 1.86

Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science (1992) 1.85

Characterization of mouse mammary tumor virus gag-pro gene products and the ribosomal frameshift site by protein sequencing. Proc Natl Acad Sci U S A (1987) 1.81

Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses. Proc Natl Acad Sci U S A (1986) 1.80

Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J Virol (1990) 1.75

Murine leukemia virus gag polyproteins: the peptide chain unique to Pr80 is located at the amino terminus. Virology (1978) 1.73

Congenital rubella syndrome as a systemic infection. Studies of affected infants born in Philadelphia, U.S.A. Br Med J (1965) 1.70

Probes of the conduction process of a voltage-gated Cl- channel from Torpedo electroplax. J Gen Physiol (1981) 1.66

Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II. J Biol Chem (1981) 1.65